These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 9233865)

  • 1. Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease.
    Dattwyler RJ; Luft BJ; Kunkel MJ; Finkel MF; Wormser GP; Rush TJ; Grunwaldt E; Agger WA; Franklin M; Oswald D; Cockey L; Maladorno D
    N Engl J Med; 1997 Jul; 337(5):289-94. PubMed ID: 9233865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease.
    Klempner MS; Hu LT; Evans J; Schmid CH; Johnson GM; Trevino RP; Norton D; Levy L; Wall D; McCall J; Kosinski M; Weinstein A
    N Engl J Med; 2001 Jul; 345(2):85-92. PubMed ID: 11450676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group.
    Gerber MA; Shapiro ED; Burke GS; Parcells VJ; Bell GL
    N Engl J Med; 1996 Oct; 335(17):1270-4. PubMed ID: 8857006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxycycline versus ceftriaxone for the treatment of patients with chronic Lyme borreliosis.
    Ogrinc K; Logar M; Lotric-Furlan S; Cerar D; Ruzić-Sabljić E; Strle F
    Wien Klin Wochenschr; 2006 Nov; 118(21-22):696-701. PubMed ID: 17160610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness of oral as compared with intravenous antibiotic therapy for patients with early Lyme disease or Lyme arthritis.
    Eckman MH; Steere AC; Kalish RA; Pauker SG
    N Engl J Med; 1997 Jul; 337(5):357-63. PubMed ID: 9233874
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis.
    Feder HM; Abeles M; Bernstein M; Whitaker-Worth D; Grant-Kels JM
    Clin Dermatol; 2006; 24(6):509-20. PubMed ID: 17113969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The recurrence of Lyme arthritis].
    Łapiński TW; Grzeszczuk A; Prokopowicz D
    Pol Merkur Lekarski; 2003 Mar; 14(81):236-8. PubMed ID: 12914103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite.
    Nadelman RB; Nowakowski J; Fish D; Falco RC; Freeman K; McKenna D; Welch P; Marcus R; Agüero-Rosenfeld ME; Dennis DT; Wormser GP;
    N Engl J Med; 2001 Jul; 345(2):79-84. PubMed ID: 11450675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis.
    Dotevall L; Hagberg L
    Clin Infect Dis; 1999 Mar; 28(3):569-74. PubMed ID: 10194080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
    Wells WG; Woods GL; Jiang Q; Gesser RM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis.
    Borg R; Dotevall L; Hagberg L; Maraspin V; Lotric-Furlan S; Cimperman J; Strle F
    Scand J Infect Dis; 2005; 37(6-7):449-54. PubMed ID: 16012005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lyme arthritis in children and adolescents: outcome 12 months after initiation of antibiotic therapy.
    Bentas W; Karch H; Huppertz HI
    J Rheumatol; 2000 Aug; 27(8):2025-30. PubMed ID: 10955347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythema migrans in the immunocompromised host.
    Maraspin V; Lotric-Furlan S; Cimperman J; Ruzić-Sabljić E; Strle F
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):923-32. PubMed ID: 10666803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic treatment duration and long-term outcomes of patients with early lyme disease from a lyme disease-hyperendemic area.
    Kowalski TJ; Tata S; Berth W; Mathiason MA; Agger WA
    Clin Infect Dis; 2010 Feb; 50(4):512-20. PubMed ID: 20070237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early disseminated borreliosis with multiple erythema migrans and elevated liver enzymes: case report and literature review.
    Benedix F; Weide B; Broekaert S; Metzler G; Frick JS; Burgdorf WH; Röcken M; Schaller M
    Acta Derm Venereol; 2007; 87(5):418-21. PubMed ID: 17721649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
    Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D
    Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology and therapy of Lyme arthritis and other manifestations of Lyme borreliosis in Germany: results of a nation-wide survey].
    Priem S; Munkelt K; Franz JK; Schneider U; Werner T; Burmester GR; Krause A
    Z Rheumatol; 2003 Oct; 62(5):450-8. PubMed ID: 14579032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stage-oriented treatment of Lyme borreliosis].
    Fingerle V; Wilske B
    MMW Fortschr Med; 2006 Jun; 148(25):39-41. PubMed ID: 16859159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of erythema migrans in spite of treatment with antibiotics after a tick bite.
    Maraspin V; Lotric-Furlan S; Strle F
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):616-9. PubMed ID: 12422612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral doxycycline versus intravenous ceftriaxone for treatment of multiple erythema migrans: an open-label alternate-treatment observational trial.
    Stupica D; Velušcek M; Blagus R; Bogovic P; Rojko T; Cerar T; Strle F
    J Antimicrob Chemother; 2018 May; 73(5):1352-1358. PubMed ID: 29385444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.